LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.70 | 84.90 | 488 | 8484 | 0.0575 | 0.3012 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.70 | 84.90 | 2974 | 8484 | 0.3505 | 0.7080 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.41 | 84.90 | 282 | 8766 | 0.0322 | 0.1966 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.41 | 84.90 | 2588 | 8766 | 0.2952 | 0.6666 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.41 | 84.90 | 483 | 8766 | 0.0551 | 0.2968 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.41 | 84.90 | 3062 | 8766 | 0.3493 | 0.7090 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.11 | 84.90 | 310 | 8988 | 0.0345 | 0.2123 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.11 | 84.90 | 2709 | 8988 | 0.3014 | 0.6734 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.11 | 84.90 | 519 | 8988 | 0.0577 | 0.3089 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.11 | 84.90 | 3159 | 8988 | 0.3515 | 0.7121 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.81 | 84.90 | 321 | 9132 | 0.0352 | 0.2178 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.81 | 84.90 | 2785 | 9132 | 0.3050 | 0.6773 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.81 | 84.90 | 442 | 9132 | 0.0484 | 0.2769 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.81 | 84.90 | 3264 | 9132 | 0.3574 | 0.7172 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.52 | 84.90 | 336 | 9214 | 0.0365 | 0.2256 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.52 | 84.90 | 2867 | 9214 | 0.3111 | 0.6829 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.52 | 84.90 | 533 | 9214 | 0.0578 | 0.3122 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.52 | 84.90 | 3443 | 9214 | 0.3737 | 0.7290 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.22 | 84.90 | 325 | 9343 | 0.0348 | 0.2189 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.22 | 84.90 | 2995 | 9343 | 0.3205 | 0.6911 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.22 | 84.90 | 527 | 9343 | 0.0564 | 0.3089 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.22 | 84.90 | 3501 | 9343 | 0.3747 | 0.7305 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.93 | 84.90 | 386 | 8970 | 0.0430 | 0.2526 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.93 | 84.90 | 3115 | 8970 | 0.3472 | 0.7089 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.93 | 84.90 | 535 | 8970 | 0.0596 | 0.3150 | MN20160318_Q02 | L16 |